ArticleCase reports in dermatology
Atrophic Pityriasis Versicolor: 3 Case Reports.
Article in Case reports in dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pityriasis versicolor is a common epidermal mycotic infection, well known in its classic hypo- or hyperpigmented macular form. However, its atrophic variant, first described in 1971, remains rare and poorly documented. The underlying cause of this variant has yet to be determined. Case Presentation: We report 3 cases of patients treated with topical steroids for inflammatory skin diseases (atopic dermatitis, cutaneous scleroderma, and mycosis fungoides) who developed erythematous and squamous atrophic lesions on their back during follow-up. Complete resolution of both patches and atrophy was observed following the discontinuation of topical steroids and the onset of topical and systemic antifungal therapy. Conclusion: Atrophic pityriasis versicolor is a disease which deserves to be highlighted to prevent misdiagnosis with other severe dermatological conditions also presenting with skin atrophy, as to avoid lesions worsening due to inappropriate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.